Zenith Therapeutics
PrivateLast Round
Series A
Aug 30, 2024
Total Funding Raised
$45M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Zenith Therapeutics operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a Series A round in August 2024.
Zenith Therapeutics is a biotechnology company that develops a transcription factor modulating drug discovery platform to target previously inaccessible oncology pathways through native protein interactions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zenith Therapeutics Comparables
Compare Zenith Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vicinitas Therapeutics | 84% | |
| Proxygen | 81% | |
| Flare Therapeutics | 81% |
For institutional investors. Book with your work email.
Zenith Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Zenith Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| Versant Ventures | Series A |
| Nextech Invest | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 5175% MoM, from 24 to 1.3K.
- Feb 20, 2026
Grew 55% QoQ, from 11 to 17 employees.
For institutional investors. Book with your work email.
Zenith Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Zenith Therapeutics's valuation, stock price, and market status.
Is Zenith Therapeutics a public or private company?
Zenith Therapeutics is a private company.
What is the current stock price of Zenith Therapeutics?
Zenith Therapeutics is a private company, so its shares have no public market price. Caplight tracks Zenith Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Zenith Therapeutics worth (valuation)?
Valuation information for Zenith Therapeutics is not publicly available.
Can I buy Zenith Therapeutics stock?
Zenith Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Zenith Therapeutics's last funding round?
Zenith Therapeutics's most recent funding round was Series A on August 30, 2024.
Who are the main investors in Zenith Therapeutics?
Key investors in Zenith Therapeutics include Andreessen Horowitz, Versant Ventures.
Will Zenith Therapeutics IPO soon?
No public IPO plans have been announced for Zenith Therapeutics.
How can I track Zenith Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Zenith Therapeutics's shares on secondary markets.